The American Board of Internal Medicine's New Longitudinal Assessment Option and What It Means for Infectious Disease Specialists.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33005939.
- Also identified by DOI 10.1093/cid/ciaa1493.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As members of the American Board of Internal Medicine's (ABIM) Infectious Disease (ID) Board we've heard from many of our colleagues asking for greater flexibility in maintaining their ABIM Board Certification. The ID Board-and ABIM as a whole-has engaged with the physician community over the past several years to gain a deeper understanding of what is most important to them, and how an enhanced Maintenance of Certification (MOC) program could support their commitment to keeping up with advances in medical knowledge. This article serves as an update about how ABIM has evolved its assessments over time and on our progress in developing a new longitudinal pathway that is anticipated to become available in most specialties in 2022, and will launch in ID in 2023.
Medical subject headings
- Communicable Diseases
- Medicine
- Physicians